Altre lingue Fredun Pharmaceuticals Limited

Azioni

FREDUN6

INE194R01017

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:56 13/06/2024			Variaz. 5gg	Var. 1 gen.
918,2 ^INR	+15,49%		+14,65%	+5,69%

07/05	Fredun Pharmaceuticals Limited progetta di costruire un nuovo impianto per la produzione di alimenti funzionali per il suo segmento veterinario	CI
07/05	Fredun Pharmaceuticals Limited riporta i risultati degli utili per l'intero anno terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24	10/05
Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9%	08/05
Fredun Pharmaceuticals Limited Plans to Put a New Facility for Production of Functional Foods for its Veterinary Segment	07/05
Fredun Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	07/05
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	07/05
Fredun Pharmaceuticals Secures Orders from Sea Countries, Expands Product Development in Veterinary Care, and Advances Orthopaedic Applications	12/02
Fredun Pharmaceuticals Limited Announces Appointment of Ms. Daisy Cyril Dsouza as Additional Independent Director	24/11
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	08/11
Fredun Pharmaceuticals Limited Declared A Dividend At 7% on the Equity Shares of the Company for the Financial Year Ended March 31, 2023	30/09/23
Fredun Pharmaceuticals Limited Proposes Dividend for the Financial Year Ended March 31, 2023	06/09/23
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	19/07/23
Fredun Pharmaceuticals Limited Approves the Resignation of Dr. Chandrakant Shah as Independent Director	19/07/23
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/05/23
Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23	24/05/23
Fredun Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	27/01/23
Fredun Pharmaceuticals Limited announced that it has received INR 275.691377 million in funding	27/12/22
Fredun Pharmaceuticals Limited Announces Change in Registered Office Address	13/12/22
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	30/09/22
Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding	27/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Fredun Pharmaceuticals Limited

Azioni

FREDUN6

INE194R01017

Altre lingue

Filtri